NOVACYT FULL YEAR 2016 RESULTS DELIVER DOUBLE DIGIT SALES GROWTH Strong start to 2017 accelerating trajectory towards profitability

Novacyt FY16 financial results PR ENG

Paris, France and Cambridge, UK – 27 April 2017 – Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, today announces its financial results for the year ended 31 December 2016.